FDA Inspection 780558 — Haupt Pharma Wuelfing GmbH
The FDA completed an inspection of Haupt Pharma Wuelfing GmbH on Apr 20, 2012 in Gronau (Leine). The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 20, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gronau (Leine) (Germany)